Opnol (Dexamethasone Sodium Phosphate)

Dexamethasone sodium phosphate, the active ingredient in Opnol, is a corticosteroid presented as a sterile injectable solution for intravenous use. It is employed to reduce inflammation and modify immune responses in a variety of acute and chronic medical conditions. GNH USA supplies Opnol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

GNH USA supplies Opnol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Opnol (dexamethasone sodium phosphate) acts on inflammatory and immune‑mediated pathways. - Acute inflammation: Provides rapid reduction of swelling, pain and erythema in severe acute inflammatory states. - Allergic reactions: Mitigates the severity of the acute systemic reaction of h     -   -